Catherine Goodman BA MSc PhD
- Catherine Goodman's Contacts
- Room 323
- 15-17 Tavistock Place
- WC1H 9SH
- T: 02079272388
I've been working in the field of health economics and health systems analysis at LSHTM since 1997. After a first degree in economics at Cambridge, and a Masters in development economics at SOAS, I spent two years working as an economic planner in the Ministry of Health and Social Welfare in Lesotho. After joining LSHTM my work mainly focused on the economics of malaria control, and I completed a PhD on the retail sector and malaria control in Tanzania. Between 2006 and 2011 I was based with the Kenyan Medical Research Institute (KEMRI) / Wellcome Trust Research Programme in Nairobi. I am now working in London again, where my work focuses on understanding the private health care sector, access to malaria treatment and improving peripheral public health facility financial and management systems.
I am the module organiser for the distance learning course Economic Analysis for Health Policy, and also teach on the sister face-to-face module of the same name. I currently supervise four research degree students.
A key focus of my research is on improving access to malaria treatment, and particularly the potential stengths and weaknesses of the commercial retail sector in contributing to this goal. I have been involved in the Independent Evaluaton of the Affordable Medicines Facility-malaria (AMFm) in 7 countries; analysis of the private sector distribution chains for antimalarials in 7 countries (ACTwatch); and evaluations of the strategies to enhance access to and targeting of antimalarial combination therapy in Kenya and Tanzania (ACT Consortium).
I am a member of the DFID-funded Consortium for research on Responsive and Resilient Health Systems (RESYST) which aims to encourage policy and management changes that enhance the resilience and responsiveness of health systems in low and middle income countries to promote health and health equity and to reduce poverty. In Kenya I am involved in the evaluation of the roll out of the Health Sector Services Fund (HSSF) which involves the direct provision of funds to rural health centres and dispensaries; and in analysis of the impact of devolution on health systems.
Finally, I am part of the Project Management Team for the Maternal Healthcare Markets Evaluation Team (MET), which focuses on innovative private sector strategies to enhance maternal health. Within this, I am leading a study of the nature of competition in the market for provision of maternal health care services in India.
- Complex interventions
- Economic evaluation
- Global Health
- Health care financing
- Health care policy
- Health policy
- Health sector development
- Health systems
- Impact evaluation
- Maternal health
- Private sector
- Qualitative methods
- Social Sciences
Disease and Health Conditions
- East Asia & Pacific (developing only)
- Least developed countries: UN classification
- South Asia
- Sub-Saharan Africa (developing only)
- Access To Care
- Access To Medicines
- Community Based Treatment Of Fever
- Community Health Workers
- Cost Effectiveness Analysis
- Drug Quality
- Health Economics
- Health Sector Reform
- Malaria Centre
Understanding private sector antimalarial distribution chains: a cross-sectional mixed methods study in six malaria-endemic countries.
Palafox, B. ; Patouillard, E. ; Tougher, S. ; Goodman, C. ; Hanson, K. ; Kleinschmidt, I. ; Rueda, S.T. ; Kiefer, S. ; O'Connell, K.A. ; Zinsou, C. ; Phok, S. ; Akulayi, L. ; Arogundade, E. ; Buyungo, P. ; Mpasela, F. ; Chavasse, D. ;
PLoS One, 2014; 9(4):e93763
Cluster Randomized Trial of Text Message Reminders to Retail Staff in Tanzanian Drug Shops Dispensing Artemether-Lumefantrine: Effect on Dispenser Knowledge and Patient Adherence.
Bruxvoort, K. ; Festo, C. ; Kalolella, A. ; Cairns, M. ; Lyaruu, P. ; Kenani, M. ; Kachur, S.P. ; Goodman, C. ; Schellenberg, D. ;
Am J Trop Med Hyg, 2014;
Getting antimalarials on target: impact of national roll-out of malaria rapid diagnostic tests on health facility treatment in three regions of Tanzania.
Bruxvoort, K.; Kalolella, A.; Nchimbi, H.; Festo, C.; Taylor, M.; Thomson, R.; Cairns, M.; Thwing, J.; Kleinschmidt, I.; Goodman, C.; Kachur, S.P.;
Trop Med Int Health, 2013; 18(10):1269-82
Protecting the public or setting the bar too high? Understanding the causes and consequences of regulatory actions of front-line regulators and specialized drug shop operators in Kenya.
Wafula, F.; Molyneux, C.; Mackintosh, M.; Goodman, C.;
Soc Sci Med, 2013; 97:220-7
Effect of the Affordable Medicines Facility-malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data.
Tougher, S.; ACTwatch Group (inc; Palafox, B.;) Ye, Y.; Amuasi, J.H.; Kourgueni, I.A.; Thomson, R.; Goodman, C.; Mann, A.G.; Ren, R.; Willey, B.A.; Adegoke, C.A.; Amin, A.; Ansong, D.; Bruxvoort, K.; Diallo, D.A.; Diap, G.; Festo, C.; Johanes, B.; Juma, E.; Kalolella, A.; Malam, O.; Mberu, B.; Ndiaye, S.; Nguah, S.B.; Seydou, M.; Taylor, M.; Rueda, S.T.; Wamukoya, M.; Arnold, F.; Hanson, K.;
Lancet, 2012; 380(9857):1916-26
The Impact of Retail-Sector Delivery of Artemether-Lumefantrine on Malaria Treatment of Children under Five in Kenya: A Cluster Randomized Controlled Trial
Kangwana, B.P.; Kedenge, S.V.; Noor, A.M.; Alegana, V.A.; Nyandigisi, A.J.; Pandit, J.; Fegan, G.W.; Todd, J.E.; Brooker, S.; Snow, R.W.; Goodman, C.A.;
Plos Medicine, 2011; 8(5):e1000437
Health facility committees and facility management - exploring the nature and depth of their roles in Coast Province, Kenya.
Goodman, C. ; Opwora, A. ; Kabare, M. ; Molyneux, S. ;
BMC Health Serv Res, 2011; 11:229
Direct facility funding as a response to user fee reduction: implementation and perceived impact among Kenyan health centres and dispensaries.
Opwora, A.; Kabare, M.; Molyneux, S.; Goodman, C.;
Health Policy Plan, 2010; 25(5):406-18
- → View all Catherine Goodman 's publications